In the context of Alzheimer's treatment, what does the drug name 'Aricept' refer to?

Aricept, known generically as donepezil, is classified as an acetylcholinesterase inhibitor. This class of medications works by blocking the enzyme acetylcholinesterase, which breaks down acetylcholine, a neurotransmitter important for memory and cognitive function. By inhibiting this enzyme, Aricept increases the levels of acetylcholine in the brain, which can help improve symptoms related to cognitive decline in Alzheimer's disease.

The mechanism of action is central to its effectiveness in managing Alzheimer's symptoms, making it a cornerstone treatment option in this therapeutic area. The enhancement of cholinergic signaling plays a critical role in mitigating some of the cognitive deficits associated with dementia. Thus, identifying Aricept as an acetylcholine esterase inhibitor is essential for understanding its application in the treatment of Alzheimer's disease.